Pharming Group (OTCMKTS:PHGUF – Get Free Report)’s share price rose 13.5% during mid-day trading on Monday . The stock traded as high as $0.86 and last traded at $0.86. Approximately 1,000 shares were traded during trading, a decline of 74% from the average daily volume of 3,800 shares. The stock had previously closed at $0.75.
Pharming Group Stock Performance
The stock’s 50-day simple moving average is $0.79 and its 200 day simple moving average is $0.88. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.43 and a quick ratio of 1.16. The stock has a market capitalization of $558.76 million, a P/E ratio of -85.65 and a beta of 1.18.
About Pharming Group
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.
Featured Articles
- Five stocks we like better than Pharming Group
- How is Compound Interest Calculated?
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- What Investors Need to Know to Beat the Market
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- What is the NASDAQ Stock Exchange?
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
